Table 2. Clinical conditions and groups that benefit from 25-hydroxyvitamin (25[OH]D) concentrations above 30 ng/mL.
Groups | Clinical Conditions |
---|---|
Elderly (> 65 years) Pregnant women | Osteoporosis (primary or secondary) Fractures due to fragility |
Metabolic bone diseases (osteomalacia, osteogenesis imperfecta, primary hyperparathyroidism) Secondary hyperparathyroidism | |
Sarcopenia Recurring falls Chronic renal disease | |
Malabsorption syndrome | |
Liver failure | |
Diabetes mellitus type 1 | |
Cancer |